DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.66T
Revenue (ttm)	4.98T
Net Income (ttm)	891.34B
Shares Out	130.75M
EPS (ttm)	6,816.87
PE Ratio	15.33
Forward PE	14.34
Dividend	10,000.00 (9.35%)
Ex-Dividend Date	n/a

Volume	34,748
Average Volume	18,316
Open	107,000
Previous Close	106,700
Day's Range	105,600 - 108,000
52-Week Range	87,000 - 110,700
Beta	0.41
RSI	55.58
Earnings Date	Jan 21, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceuti...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.